Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Rank in Stocks #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Share Price
$0.0001
Last synced: 2026-07-17
Market Cap
$981.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Omnimmune Holdings, Inc. (OMMH)

Category

Stock split history for Omnimmune Holdings, Inc. (OMMH)
Omnimmune Holdings, Inc. stock (symbol: OMMH) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 12, 2026.
One OMMH share bought prior to Aug 12, 2026 would equal to 0 OMMH shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR